The total raised by Oxford’s spinouts was down from $229m year-on-year, though university tech transfer office OUI also marked its largest ever single exit during the period.

Building on KU Leuven and Amsterdam UMC research, Cytura hopes to find small molecule candidates that combat the issue of genomic variability in cancer.

Victor Christou has stepped down from his position as chief executive of Cambridge Innovation Capital just weeks after helping the unit raise $196m in additional funding.

Commerzbank-backed Bankin' landed $22.6m in the round, which will enable the financial management app developer to hire 20 additional staff by the end of the year.

Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Chalmers University of Technology’s investment and incubator unit recorded a $79,000 operating loss for the year, during which it backed 34 portfolio companies with a total of $3.5m in funding.

Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.

Legal & General co-led the $32.8m series C round, which will fund the financial wellbeing platform's growth in the UK and US.

SEB has formed a venture capital vehicle, Fairpoint Capital, to invest in B2B-focused startups out of a $97m fund with ex-SEB Venture Capital president Frederick Johansson as its head.

IDF Innov-allied brain implant developer Neurallys plans to market sensors that measure intracranial pressure to combat the severe neurological complication hydrocephalus.